METABOLIC AND THERAPEUTIC EFFECTS OF ALLOPURINOL IN PATIENTS WITH LEUKEMIA AND GOUT

被引：45
|
作者：
VOGLER, WR
BAIN, JA
HUGULEY, CM
PALMER, HG
LOWREY, ME
机构：
来源：
AMERICAN JOURNAL OF MEDICINE | 1966年 / 40卷 / 04期
关键词：
D O I：
10.1016/0002-9343(66)90118-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：548 / &
相关论文
共 50 条
  • [31] ALLOPURINOL IN TREATMENT OF GOUT
    RUNDLES, RW
    METZ, EN
    SILBERMAN, HR
    ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) : 229 - +
  • [32] ALLOPURINOL IN TREATMENT OF GOUT
    SEEBACH, LM
    JOURNAL-LANCET, 1967, 87 (10): : 411 - +
  • [33] ALLOPURINOL IN TREATMENT OF GOUT
    WYNGAARD.JB
    RUNDLES, RW
    METZ, EN
    ANNALS OF INTERNAL MEDICINE, 1965, 62 (04) : 842 - +
  • [34] ALLOPURINOL IN GOUT THERAPY
    KLEIN, G
    GRIENDL, W
    KALB, R
    ZEITSCHRIFT FUR RHEUMAFORSCHUNG, 1968, 27 (11-1): : 455 - &
  • [35] The Efficacy and Tolerability of Allopurinol Dose Escalation in Patients with Gout
    Radak-Perovic, Marija
    Zlatkovic-Svenda, Mirjana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (5-6) : 333 - 336
  • [36] Treatment of tophaceous gout in patients intolerant to allopurinol.
    Grahame, R
    Simmonds, A
    McBride, M
    Marsh, F
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S151 - S151
  • [37] Adherence and Persistence to Allopurinol among Hypertensive Patients with Gout
    Perreault, Sylvie
    Nuevo, Javier
    Baumgartner, Scott
    Morlock, Rob
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 500 - 501
  • [38] Current management of gout in patients unresponsive or allergic to allopurinol
    Bardin, T
    JOINT BONE SPINE, 2004, 71 (06) : 481 - 485
  • [39] ADHERENCE AND PERSISTENCE TO ALLOPURINOL AMONG HYPERTENSIVE PATIENTS WITH GOUT
    Perreault, S.
    Nuevo, J.
    Baumgartner, S.
    Morlock, R.
    VALUE IN HEALTH, 2015, 18 (07) : A655 - A655
  • [40] THE EFFECT OF BENZBROMARONE ON ALLOPURINOL OXYPURINOL KINETICS IN PATIENTS WITH GOUT
    MULLER, FO
    SCHALL, R
    GROENEWOUD, G
    HUNDT, HKL
    VANDERMERWE, JC
    VANDYK, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (01) : 69 - 72
12345